Stimulation of Lymphocyte Guanylate Cyclase by Arachidonic Acid and HETEs

  • Ronald G. Coffey
  • John W. Hadden
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)


Mitogen activation of human peripheral blood lymphocytes (HPBL) occurs as a consequence of several early membrane events. One of the earliest is the Ca2+ -dependent stimulation of guanylate cyclase (Coffey et al., 1981). Experiments with the T-cell mitogens phytohemagglutinin (PHA), concanavalin A (Con A), and phorbol myristate acetate (PMA) suggested that phospholipase and lipoxygenase activation are important in the sequence of early membrane events leading to guanylate cyclase stimulation, cGMP accumulation, and DNA synthesis (Coffey and Hadden,1981, 1983a,b). Cyclooxygenase (Coffey et al., 1981) and thromboxane synthetase activities (Gordon et al., 1981) were not found to be essential for mitogenesis.


Phorbol Myristate Acetate Guanylate Cyclase Mitogen Activation Phorbol Myristate Acetate Soluble Guanylate Cyclase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aldiger, J.C, Gualde, N., Mexmain, C.R., Ratinaud, M.H., and Rigaud, M., 1984, Immuno-suppression induced in vivo by 15-hydroxyeicosatetraeoic acid, Prostaglandins Leukotrienes Med. 13:99–108.CrossRefGoogle Scholar
  2. Bailey, J.M., Bryant, R.W., Low, C.E., Pupillo, M.B., and Vanderhoek, J.Y., 1982, Regulation of T-lymphocyte mitogenesis by the leukocyte product 15-hydroxy-eicosatetraenoic acid (15-HETE), Cell. Immunol. 67:112–120.PubMedCrossRefGoogle Scholar
  3. Brandwein, H.J., Lewicki, J.A., and Murad, F., 1981, Reversible inactivation of guanylate cyclase by mixed disulfide formation, J. Biol. Chem. 256:2958–2962.PubMedGoogle Scholar
  4. Coffey, R. G., and Hadden, J. W., 1981, Arachidonate and metabolites in mitogen activation of lymphocyte guanylate cyclase, in: Advances in Immunopharmacology (J. Hadden, L. Chedid, P. Mullen, and F. Spreafico, eds.), Pergamon Press, Oxford, pp. 365–373.Google Scholar
  5. Coffey, R. G., and Hadden, J. W., 1983a, Calcium and guanylate cyclase in lymphocyte activation, in: Advances in Immunopharmacology, Vol. 2 (J. W. Hadden, L. Chedid, P. Dukor, F. Spreafico, and D. Willoughby, eds.), Pergamon Press, Oxford, pp. 87–94.Google Scholar
  6. Coffey, R.G., and Hadden, J.W., 1983b, Phorbol myristate acetate stimulation of lymphocyte guanylate cyclase and cyclic GMP phosphodiesterase and reduction of adenylate cyclase, Cancer Res. 43:150–158.PubMedGoogle Scholar
  7. Coffey, R.G., Hadden, E.M., and Hadden, J.W., 1981, Phytohemagglutinin stimulation of guanylate cyclase in human lymphocytes, J. Biol. Chem. 256:4418–4424.PubMedGoogle Scholar
  8. Craven, P.A., and DeRubertis, F.R., 1982, Relationship between calcium stimulation and cyclic GMP and lipid peroxidation in the rat kidney: Evidence for involvement of calmodulin and separate pathways of peroxidation in cortex versus inner medulla, Metabolism 31:103–116.PubMedCrossRefGoogle Scholar
  9. Goetzl, E.J., 1981, Selective feed-back inhibition of the 5-lipoxygenation of arachidonic acid in human T-lymphocytes, Biochem. Biophys. Res. Commun. 101:344–350.PubMedCrossRefGoogle Scholar
  10. Goldberg, N.D., Graff, G., Haddox, M.K., Stephenson, J.H., Glass, D.B., and Moser, M.E., 1978, Adv. Cyclic Nucleotide Res. 9:101–13PubMedGoogle Scholar
  11. Gordon, D., Nouri, A.M.E., and Thomas, R.U., 1981, Selective inhibition of thromboxane biosynthesis in human blood mononuclear cells and the effects on mitogen-stimulated lymphocyte proliferation, Br. J. Pharmacol. 74:469–475.PubMedCrossRefGoogle Scholar
  12. Hadden, J.W., Coffey, R.G., Ananthakrishnan, R., and Hadden, E.M., 1979, Cyclic nucleotides and calcium in lymphocyte regulation and activation, Ann. N.Y. Acad. Sci. 332:241–254.PubMedCrossRefGoogle Scholar
  13. Haddox, M.K., and Goldberg, N.D., 1977, Cyclic GMP metabolism and involvement in biological regulation, Annu. Rev. Biochem. 46:823–896.PubMedCrossRefGoogle Scholar
  14. Novogrodsky, A., Ravid, A., Rubin, A.L., and Stenzel, K.H., 1982, Hydroxyl radical scavengers inhibit lymphocyte mitogenesis, Proc. Natl. Acad. Sci. U.S.A. 79:1171–1174.PubMedCrossRefGoogle Scholar
  15. Parker, C.W., Stenson, W.F., Huber, M.G., and Kelly, J.P., 1979, Formation of thromboxane B2 and hydroxyarachidonic acids in purified human lymphocytes in the presence and absence of PHA, J. Immunol. 122:1572–1577.PubMedGoogle Scholar
  16. Vanderhoek, J.Y., Bryant, R.W., and Bailey, J.M., 1982, Regulation of leukocyte and platelet lipoxygenases by hydroxyeicosanoids, Biochem. Pharmacol. 31:3463–3467.PubMedCrossRefGoogle Scholar
  17. Vesin, M.F., Bourgoin, S., Leiber, D., and Harbon, S., 1984, Lipoxygenase and cyclooxygenase products of arachidonic acid in uterus. Selective interaction with the cGMP and cAMP systems, Prostaglandins Leukotrienes Med. 13:75–78.CrossRefGoogle Scholar
  18. White, A.A., Karr, D.B., and Patt, C.S., 1982, Role of lipoxygenase in the O2-dependent activation of soluble guanylate cyclase from rat lung, Biochem. J. 204:382–392.Google Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • Ronald G. Coffey
    • 1
  • John W. Hadden
    • 1
  1. 1.Program of ImmunopharmacologyUniversity of South Florida Medical CollegeTampaUSA

Personalised recommendations